NVCR gains Japan NHI reimbursement for Optune Lua in advanced NSCLC, expanding patient access and supporting adoption of its ...

The alternative medicine industry is expanding rapidly, fueled in large part by the surge of health-related content on social ...

Nintedanib treatment reduces the levels of circulating cancer antigen 125 in patients with progressive pulmonary fibrosis.

Colorectal cancer is increasing in younger patients and is now the leading cause of cancer death in those under age 50, yet those patients lack support.

Incyte announced Friday that the FDA issued a complete response letter for its PD-1 inhibitor Zynyz as a first-line treatment for non-small cell lung cancer.

Radon, an odorless radioactive gas that seeps from soil into homes, is responsible for an estimated 21,000 lung cancer deaths each year in the United States. That figure, drawn from federal risk ...

Real-world community study finds Enhertu in HER2-low metastatic breast cancer has trial-like discontinuation rates; ILD remains key toxicity.

When I was an oncology nurse, a 44-year-old patient named Madeline forever changed my perception of death. She had gallbladder cancer and one day broke her hip. This sent her to the hospital, ...

March is Colon Cancer Awareness month. According to a study published in January 2026 by the Journal of American Medical Association, colorectal cancer is now the leading cause of cancer-related death ...

AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has been accepted and granted Priority Review in the US for the treatment of ...

Presentations highlight real‑world dosing and titration patterns in youth, and post‑prandial glucose management strategies using inhaled insulin ...

When asked about the one thing he absolutely avoids as a heart surgeon, Dr Jeremy was quick to respond. “Smoking's top of the list. I mean, I cannot come up with one single thing that does as much ...